FDA to restrict drug used in hospital robberies
Play
The Food and Drug Administration (FDA) may change the animal sedative Xylazine from its status as a dangerous drug that can be be sold over the counter by pharmacists to being a specially-controlled drug for sale only at hospitals and animal clinics.
It had received reports the drug had been used by thieves to spike drinks of people seeking treatment at public hospitals in order to rob them of valuables.
FDA secretary-general Boonchai Somboonsuk said Monday that the FDA had consulted with related agencies, especially the Livestock Development Department and expert veterinarians about the change of status plan for Xylazine.
The Nation
